In fact, a study undertaken in patients with metastatic HER-2-positive tumors demonstrated an efficient tumor accumulation of 64Cu-radiolabeled-MM302 liposomes [134], indicating that this targeting strategy was effective. The gene discussed is ERBB2; the disease is neoplasm.